Definitive and neoadjuvant radiochemotherapy of squamous cell carcinoma of the oesophagus

Onkologie

Volumn 27, Issue 1, 2004, Pages 39-44

  Fietkau, R ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Neoadjuvant therapy; Oesophageal cancer; Radiochemotherapy, concurrent

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; VINBLASTINE;

BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CLINICAL TRIAL; ESOPHAGUS CARCINOMA; HUMAN; IMMUNE DEFICIENCY; INFECTION RATE; INTERMETHOD COMPARISON; LUNG TOXICITY; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; REFLUX ESOPHAGITIS; REVIEW; SQUAMOUS CELL CARCINOMA; SYNDROME DELINEATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 1542408479     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075604     Document Type: Review

References (39)

1. Araujo CMM, Souhami L, Gil RA, Carvalho R, Garcia JA, Froimtchuk MJ, Pinto LH, Canary PC: A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991;67:2258-2261.
2. Slabber CR, Nel JS, Schoeman L, Burger W, Falkson G, Falkson CI: A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 1998;21:462-465.
3. Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, Tormey DC, Schutt AJ, Hinson J, Sischy B: Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern cooperative oncology group. Int J Radiat Oncol Biol Phys 1998;42:269-276.
4. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russel AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL: Chemoradiotherapy of locally advanced esophageal cancer. Longterm follow-up of a prospective randomized trial. JAMA 1999;281:1623-1627.
5. Wobbes T, Baron B, Paillot B, Jacob J, Haegele P, Gignoux M, Michel P, Couvreur M: Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 2001;37:470-477.
6. Rebecca WO, Richard MA: Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Conchrane Database Syst Rev 2003;(1):CD00292.
7. Wong R, Malthaner RA, Zuraw L, Rumble RB: Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: A practice guideline. Int J Radiat Oncol Biol Phys 2003;55:930-942.
8. Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg RJ, Pajak T, Salter M, Benson AB 3rd: Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1999;43:517-523.
9. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP: Phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-1174.
10. Gaspar LE, Winter K, Kocha WI, Pinover WH, Herskovic, Graham M, Gunderson L: A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy for patients with localized cancer of the esophagus (RTOG 92-07). Cancer 2000;88:988-995.
11. Fietkau R, Ell C, Hochberger J, Schneider T, Schmitt M: A new applicator for the intraluminal high-dose-rate irradiation of esophageal carcinoma. Strahlenther Onkol 1991;167:301-304.
12. Yorozu A, Dokiya T, Oki Y: High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 1999;45:271-275.
13. Calais G, Dorval E, Louisot P, Bourlier P, Klein V, Chapet S, Reynaud-Bougnoux A, Huten N, De Calan L, Aget H, Le Floch O: Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stage IIB and III esophageal carcinoma: Results of a pilot study. Int J Radiat Oncol Biol Phys 1997;38:769-775.
14. Mücke R, Ziegler PG, Libera T, Klautke G, Fietkau R: The multimodality therapy of advanced inoperable esophageal carcinoma. A retrospective analysis. Strahlenther Onkol 2000;176:350-355.
15. Gaspar LE, Nag S, Herskovic A, Mantravadi R, Speiser B: American brachytherapy society consensus guidelines for brachytherapy of esophageal cancer. Int J Radiat Oncol Biol Phys 1997;38:127-132.
16. Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino N, Yoshida S: Long-Term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:2697-2702.
17. Stahl M, Wilke H, Fink U, Stuschke M, Walz MK, Siewert JR, Molls M, Fett W, Makoski HB, Breuer N, Schmidt U, Niebel W, Sack H, Eigler FW, Seeber S: Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: Interim analysis of a phase II trial. J Clin Oncol 1996;14:829-837.
18. Stahl M, Wilke H, Fink U, Stuschke M, Walz MK, Siewert JR, Molls M, Fett W, Makoski HB, Breuer N, Schmidt U, Niebel W, Sack H, Eigler FW, Seeber S: Randomized phase III trial in locally advanced squamous cell carcinoma (SCC) of the esophagus: Chemoradiation with and without surgery. Proc Am Soc Clin Oncol 2003; abstr 1001.
19. Bedenne L, Michel P, Bouche O, Triboulet JP, Conroy T, Pezet D, Roullet B, Seitz JF, Lacourt J, Milan C: Randomized phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol 2002; abstr 519.
20. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-313.
21. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Henessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467.
22. Geh JI, Crellin M, Glynne-Jones R: Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338-356.
23. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, Mantyla M, Modig H, Munck-Wikland E, Rosengren B: Preoperative radiotherapy prolongs survival in operable esophageal carcinoma. A randomized multicenter study of preoperative radiotherapy and chemotherapy - the second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-1109.
24. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepato-Gastroenterol 1994;41:391-393.
25. Le Prise E, Etienne PL, Meunier B, Maddern G, Hassel B, Gedouin D, Boutin D, Campion JP, Launois B: A randomized study of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784.
26. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, Sahmoud T: Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997;337:161-167.
27. Kok TC, Lanschot J, Siersema PD, Overhagen HV: Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: Final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997; abstr 983
28. Medical research council oesophageal cancer working group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002;359:1727-1733.
29. Hohenberger W: Resektion des Ösophaguskarzinoms mit und ohne Chemotherapie: Eine randomisierte kontrollierte Studie. Strahlenther Onkol 2003;179:271-272.
30. Urschel JD, Vasan H, Blewett CJ: A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002;183:274-279.
31. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-543.
32. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: A meta-analysis of randomized clinical trials. Ann Surg Oncol 2003;10:754-761.
33. Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R: Preoperative chemoradiotherapy in esophageal cancer: Evidence of dose response. Proc Am Soc Clin Oncol 2000; Abstr 958
34. Eguchi R, Ide H, Nakamura T, Hayashi K, Ohta M, Okamoto F, Itoh H, Takasaki K: Analysis of postoperative complications after esophagectomy for esophageal cancer in patients receiving neoadjuvant therapy. Jpn J Thorac Cardiovasc Surg 1999; 47:552-558.
35. Hennequin C, Gayet B, Sauvanet A, Blazy A, Perniceni T, Panis Y, Mal F, Sarfati E, Valleur P, Belghiti J, Fekete F, Maylin C: Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Radiat Oncol Biol Phys 2001;49:657-664.
36. Kato H, Udagawa H, Togo A, Ando N, Tanaka O, Shinoda M, Aogi K, Yamana H, Shimizu H, Fukuda H: A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma. (JCOG 9708). Proc Am Soc Clin Oncol 2003; abstr 1147.
37. Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H: Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 1999;45:277-284.
38. de Pree C, Aapro MS, Spiliopoulos A, Popowski Y, Mermillod B, Mirimanoff RO, Alberto P: Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus. Ann Oncol 1995;6:551-557.
39. Lee JL, Kim SB, Jung HY, Lee GH, Park SI, Kim JH, Song HY, Kim WK, Lee JS: A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery (CRT-S) versus surgery (S) alone for stage II, III resectable esophageal squamous cell carcinoma: An interim analysis. Proc Am Soc Clin Oncol 2003; abstr 1043.